Mithra Pharmaceuticals SA MITRA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.22
- Day Range
- €0.22–0.22
- 52-Week Range
- €0.20–3.87
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €14.45 Mil
- Volume/Avg
- 82,336 / 408,047
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.19
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 229
- Website
- https://www.mithra.com
Comparables
Valuation
|
Metric
|
MITRA
|
SOLV
|
QEV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 3.85 | — |
Price/Book Value | — | 0.89 | — |
Price/Sales | 0.19 | — | — |
Price/Cash Flow | — | 17.84 | — |
Price/Earnings
MITRA
SOLV
QEV
Financial Strength
|
Metric
|
MITRA
|
SOLV
|
QEV
|
|---|---|---|---|
Quick Ratio | 0.49 | 0.83 | 7.59 |
Current Ratio | 1.04 | 0.83 | 7.59 |
Interest Coverage | −0.79 | 41.78 | 0.93 |
Quick Ratio
MITRA
SOLV
QEV
Profitability
|
Metric
|
MITRA
|
SOLV
|
QEV
|
|---|---|---|---|
Return on Assets (Normalized) | −19.67% | 18.99% | −3.30% |
Return on Equity (Normalized) | −402.35% | 21.62% | — |
Return on Invested Capital (Normalized) | −28.66% | 14.81% | −0.86% |
Return on Assets
MITRA
SOLV
QEV
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qvclmvhzz | Ftnh | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Vwzgdhxsmv | Jyrpy | $69.1 Bil | |
HLN
| Haleon PLC ADR | Vmfzkllz | Gbtvb | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vwrfdqjjl | Zjrw | $15.7 Bil | |
VTRS
| Viatris Inc | Jlxbfgwh | Cvdxx | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Czvzpgp | Bfft | $12.4 Bil | |
CTLT
| Catalent Inc | Kbpdkvkvc | Hjvhpb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gspfghp | Pycnm | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Nqqwlmcb | Xqgb | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gpmsyjt | Zsvpq | $3.5 Bil |